TB-500 10mg Peptide | Third-Party Tested | RemedyX Labs

Order TB-500 10mg research peptide online from RemedyX Labs. Verified batch COAs confirm purity and identity. Secure checkout, competitive pricing, and fast shipping.

TB-500 is a synthetic fragment of the naturally occurring protein thymosin beta-4, widely studied for its role in actin regulation, cellular movement, and tissue-remodeling research models. Every batch is independently tested by a third-party laboratory to confirm identity and purity, with batch-specific Certificates of Analysis (COA) available for full transparency. For laboratory research use only. Not for human or animal use. Not intended for diagnostic, therapeutic, clinical, or commercial use.

Cited Research

  • The Regenerative Peptide Thymosin β4 Accelerates the Rate of Dermal Wound Healing

    This investigation demonstrates that the regenerative peptide thymosin beta-4 accelerates the rate of dermal wound healing.

    PubMed

    View source · Read our summary

  • Thymosin β4: A Multi-Functional Regenerative Peptide — Basic Properties and Clinical Applications

    This paper outlines the basic properties and biological functions of the regenerative peptide thymosin beta-4.

    PubMed

    View source · Read our summary

  • Thymosin Beta4 Accelerates Wound Healing

    The study reports on the accelerating effect of thymosin beta-4 on the wound healing process.

    PubMed

    View source · Read our summary

  • Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion

    The study evaluated the impact of recombinant human thymosin beta-4 on cardiac dysfunction in mice and human patients following acute ST-segment elevation myocardial infarction.

    PubMed, 2025

    View source · Read our summary

  • Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury

    This study explored the neuroprotective and neurorestorative effects of thymosin beta-4 following experimental traumatic brain injury.

    PubMed, 2012

    View source · Read our summary

  • Thymosin beta4 reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock

    Researchers examined the effect of thymosin beta-4 on lethality and inflammatory mediator regulation in a model of endotoxin-induced septic shock.

    PubMed, 2003

    View source · Read our summary

  • Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblasts

    This study investigated the role of thymosin beta-4 as a chemoattractant for myoblasts following muscle injury.

    PubMed, 2010

    View source · Read our summary

  • Thymosin beta4 increases hair growth by activation of hair follicle stem cells

    Researchers studied the mechanism by which thymosin beta-4 increases hair growth through the activation of hair follicle stem cells.

    PubMed, 2004

    View source · Read our summary

  • Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent

    This investigation evaluated thymosin beta-4 as a potential agent for corneal wound healing and inflammation management.

    PubMed, 2009

    View source · Read our summary

  • Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin β-4 in the Dystrophin Deficient Mouse

    This study assessed skeletal and cardiac muscle function in dystrophin-deficient mice after the chronic administration of thymosin beta-4.

    PMC, 2010

    View source · Read our summary

  • Progress on the Function and Application of Thymosin β4

    Reviews thymosin β4 biology, tissue repair, angiogenesis and clinical-development history.

    PMC, 2021

    View source · Read our summary

  • A first-in-human, randomized, double-blind, single-ascending-dose study of recombinant human thymosin β4

    Evaluates safety, tolerability, pharmacokinetics and anti-drug antibodies for recombinant human thymosin β4.

    PubMed, 2021

    View source · Read our summary

  • Thymosin beta4 and angiogenesis: modes of action and therapeutic potential

    Reviews mechanisms connecting thymosin β4 with angiogenesis, wound repair and tumor biology.

    PubMed, 2007

    View source · Read our summary

  • Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4

    Develops analytical approaches for TB-500 detection; it is not an efficacy study.

    PubMed, 2012

    View source · Read our summary

  • Biological activities of thymosin beta4 defined by active sites in short peptide sequences

    Maps biological activities to shorter thymosin β4 sequences, including repair and anti-inflammatory functions.

    PubMed, 2010

    View source · Read our summary

  • Therapeutic potential of thymosin-beta4 and its derivative Ac-SDKP in cardiac healing after infarction

    Reviews experimental cardiac-repair data and states that clinical evidence was not yet available at publication.

    PubMed, 2006

    View source · Read our summary

  • A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers

    Examines intravenous synthetic thymosin β4 safety and pharmacokinetics.

    PubMed, 2010

    View source · Read our summary

  • Advances in the basic and clinical applications of thymosin β4

    Reviews preclinical research and several tissue-repair clinical programs.

    PubMed, 2015

    View source · Read our summary

  • Synthesis and characterization of the N-terminal acetylated 17-23 fragment of human thymosin beta 4 in TB-500

    Identifies and characterizes a thymosin β4 fragment associated with TB-500 products.

    PubMed, 2012

    View source · Read our summary

  • Thymosin beta 4 and the eye: the journey from bench to bedside

    Reviews corneal wound-healing research and ophthalmic clinical development.

    PubMed, 2018

    View source · Read our summary

Full research bibliography